Last reviewed · How we verify

NCT04287270

Respiratoy Muscle Strength in Patients With Multiple System Atrophy

Completed NA Last updated 26 March 2021
What this trial tests

NA trial testing Assesment in Multiple System Atrophy in 19 participants. Completed in 26 February 2021.

Timeline
2 February 2019
Primary endpoint
1 July 2020
26 February 2021

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment19
Start date2 February 2019
Primary completion1 July 2020
Estimated completion26 February 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 40 to 85, any sex, with Multiple System Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is; compare respiratory function parameters and respiratory muscle strength in patients with MSA compare to healthy controls, and to evaluate the results of SNIP and PImax in measuring inspiratory muscle strength in MSA patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Assesment

Trials testing the same drug.

Other recruiting trials for Multiple System Atrophy

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04287270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing